MiNK Therapeutics (INKT) Misses Q3 EPS by 65c

MiNK Therapeutics (NASDAQ: INKT) reported Q3 EPS of ($0.65).

For earnings history and earnings-related data on MiNK Therapeutics (INKT) click here.

You May Also Be Interested In

• Affirm Holdings (AFRM) PT Raised to $104 at BofA Securities
• PagerDuty, Inc. (PD) Tops Q2 EPS by 1c; offers guidance
• FinVolution (FINV) PT Lowered to $4.70 at Jefferies